RIKER LAUREN — SEC insider filings
SEC reporting owner CIK 1545439. 27 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2020-08-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 25 legs across 19 filings — 71,495 shares, $3,405,400 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 8,400 shares @ $71.14 ($597,576) in Pacira BioSciences, Inc., filed 2022-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | 27 | — | 25 legs · 71,495 sh · $3,405,400 | 51 |
Insider filings — RIKER LAUREN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Code (U): 6,881.24 @ $36.50 · Disposition to issuer (D): 55,403 @ $36.50 · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +7 more | EDGAR |
| 2026-10-09 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 6,000 @ $32.35 · Sale (S): 6,000 @ $36.32 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 6,115 @ $23.50 | EDGAR |
| 2026-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 3,187 @ $22.32 | EDGAR |
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 19,273 @ $0 | EDGAR |
| 2026-02-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 2,751 @ $20.54 · Sale (S): 4,000 @ $20.81 | EDGAR |
| 2026-01-06 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 159 @ $24.46 · Sale (S): 1,416 @ $24.24 | EDGAR |
| 2025-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 3,374 @ $26.40 · Sale (S): 5,578.34 @ $26.21 | EDGAR |
| 2025-02-04 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 30,600 @ $0 | EDGAR |
| 2025-01-06 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 159 @ $18.33 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 21,360 @ $0 · Sale (S): 3,970 @ $28.72 | EDGAR |
| 2024-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 1,843 @ $30.89 | EDGAR |
| 2024-01-04 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 159 @ $32 | EDGAR |
| 2023-07-07 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 643 @ $38.91 | EDGAR |
| 2023-06-16 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 10,000 @ $0 · Sale (S): 586 @ $37.47 · Sale (S): 5,773 @ $38.52 · Sale (S): 7 @ $39.01 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 591 @ $38.99 · Sale (S): 616 @ $37.87 | EDGAR |
| 2022-06-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 1,150 @ $61.37 · Grant/award (A): 5,850 @ $0 · Grant/award (A): 14,600 (derivative) @ $0 | EDGAR |
| 2022-03-14 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 9,300 @ $10.81 · Sale (S): 8,400 @ $71.14 · Sale (S): 900 @ $71.95 · Option exercise (M): 9,300 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 2,500 @ $10.81 · Sale (S): 2,500 @ $64.97 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 2,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2021-07-30 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 2,410 @ $10.81 · Sale (S): 2,410 @ $60.85 · Option exercise (M): 90 @ $10.81 · Sale (S): 90 @ $60.81 · Option exercise (M): 2,410 (derivative) @ $0 · Option exercise (M): 90 (derivative) @ $0 | EDGAR |
| 2021-06-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 2,600 @ $0 · Sale (S): 2,003 @ $59.85 · Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 1,047 @ $61.04 | EDGAR |
| 2021-03-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 1,520 @ $10.81 · Sale (S): 1,520 @ $73.28 · Option exercise (M): 2,000 @ $10.81 · Sale (S): 2,000 @ $70.01 · Option exercise (M): 1,520 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2020-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 3,000 @ $10.81 · Sale (S): 3,000 @ $63.81 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 3,000 @ $10.81 · Sale (S): 3,000 @ $60.34 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2020-08-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 8,180 @ $10.34 · Sale (S): 8,180 @ $60.50 · Option exercise (M): 8,180 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1545439 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs